000			02204nam a22004337a 4500
008			240723s20232023 xxu||||| |||| 00| 0 eng d
022			_a2000-9666
024			_ajchim-13-06-067 [pii]
024			_aPMC11000832 [pmc]
040			_aOvid MEDLINE(R)
099			_a38596557
245			_aParathyroid Hormone Related Peptide Hypercalcemia as a Presentation of Endometrial Clear Cell Carcinoma.
251			_aJournal of Community Hospital Internal Medicine Perspectives. 13(6):67-70, 2023.
252			_aJ Community Hosp Intern Med Perspect. 13(6):67-70, 2023.
253			_aJournal of community hospital internal medicine perspectives
260			_c2023
260			_p2023
260			_fFY2024
265			_sepublish
265			_tPubMed-not-MEDLINE
520			_aHypercalcemia is a frequent complication of solid tumors and hematologic malignancies yet is only rarely associated with endometrial clear cell carcinoma. Here we report on a 70-year-old female who presented in the context of hip fracture and was incidentally found to have humoral hypercalcemia of malignancy secondary to endometrial clear cell carcinoma. This rare association makes endometrial cancer one of the differential diagnoses to be considered when assessing incidentally found symptomatic or asymptomatic hypercalcemia in the appropriate patient population. Copyright © 2023 Greater Baltimore Medical Center.
546			_aEnglish
650			_zAutomated
651			_aMedStar Franklin Square Medical Center
651			_aMedStar Harbor Hospital
651			_aMedStar Union Memorial Hospital
656			_aHospitalist
656			_aInternal Medicine Residency
657			_aCase Reports
700			_aAdhikari, Biplov _bMUMH _cInternal Medicine Residency _dMBBS
700			_aGeorges, Claudia _bMUMH _cInternal Medicine Residency _dMD
700			_aHaas, Christopher _bMUMH
700			_aJones, Robert _bMFSMC
700			_aKoundaveety, Soumya _bMUMH
700			_aPaudel, Kalyan _bMHH
790			_aGeorges C, Adhikari B, Koundaveety S, Jones R, Paudel K, Haas C
856			_uhttps://dx.doi.org/10.55729/2000-9666.1271 _zhttps://dx.doi.org/10.55729/2000-9666.1271
942			_cART _dArticle
999			_c14236 _d14236